BZWA
NVCT icon

Blue Zone Wealth Advisors’s Nuvectis Pharma NVCT Stock Holding History

Blue Zone Wealth Advisors’s Portfolio NVCT Stock Details NVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,424
Closed -$102K – 114
2025
Q1 		$102K Buy
+10,424
New +$75.1K 0.03% 103
2024
Q2 		– Sell
-14,350
Closed -$118K – 91
2024
Q1 		$118K Buy
+14,350
New +$122K 0.04% 83

Other funds holding NVCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Blue Zone Wealth Advisors's NVCT Position: Q2 2025 in Review

Blue Zone Wealth Advisors sold out of Nuvectis Pharma (NVCT) in Q2 2025, closing a stake of 10,424 shares — an estimated $102K sold.

Blue Zone Wealth Advisors first reported a position in NVCT in Q1 2024 and held it in 2 quarters. The position peaked at $118K in Q1 2024. 47 funds tracked by Wall St. Rank hold NVCT as of Q2 2025.

  • Blue Zone Wealth Advisors reported no remaining Nuvectis Pharma position as of Q2 2025 after selling out during the quarter.
  • Blue Zone Wealth Advisors sold 10,424 Nuvectis Pharma shares in Q2 2025, an estimated $102K.
  • Blue Zone Wealth Advisors first reported a position in Nuvectis Pharma in Q1 2024 and held it in 2 quarters.
  • Blue Zone Wealth Advisors's Nuvectis Pharma position peaked at $118K in Q1 2024.
  • 47 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q2 2025.

Based on Blue Zone Wealth Advisors's 13F filing for Q2 2025, filed 24 Jul 2025.